| This article has been cited by |
| 1 | Health economics and effectiveness analysis of generic anti-diabetic medication from jan aushadhi: An ambispective study in community pharmacy | |
| Raushan Kumar Chaudhary,Melwin Johns Philip,Ashly Santhosh,Satish S. Karoli,Ramesh Bhandari,M.S. Ganachari |
| Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021;15(6)102303 |
| [DOI] |
|
| 2 | Health economics and effectiveness analysis of generic anti-diabetic medication from jan aushadhi: An ambispective study in community pharmacy | |
| A. N. Nagappa,Shvetank Bhatt |
| Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2022;15(6)287 |
| [DOI] |
|
| 3 | Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries | |
| Abdulaziz Ibrahim Alzarea,Yusra Habib Khan,Abdullah Salah Alanazi,Muhammad Hammad Butt,Ziyad Saeed Almalki,Abdullah K. AlAhmari,Saud Alsahali,Tauqeer Hussain Mallhi |
| International Journal of Environmental Research and Public Health.2022;19(13)7862 |
| [DOI] |
|
| 4 | Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries | |
| Sen Lin |
| International Journal of Environmental Research and Public Health.2019;32(13)271 |
| [DOI] |
|
| 5 | Urgency of the Implementation of Health Technology Assessment to Support Indonesian National Health Security System | |
| Gunawan Widjaja,Hotmaria H. Sijabat |
| IOP Conference Series: Materials Science and Engineering.2019;508(13)012144 |
| [DOI] |
|
| 6 | Impact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patientsImpact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patients | |
| BhavyaH Vyas,NishitaH Darji,DevangA Rana,KaushalY Vyas,SupriyaD Malhotra |
| Perspectives in Clinical Research.2021;12(2)76 |
| [DOI] |
|
| 7 | Spinal Muscular Atrophy Therapeutics in India: Parental Hopes and Despair! | |
| Renu Suthar,Amol N Patil |
| Annals of Neurosciences.2021;28(3-4)112 |
| [DOI] |
|
| 8 | Expert Opinion About the Pharmacoeconomic Edge of Low-Cost Dapagliflozin in Type 2 Diabetes Mellitus in Indian Clinical Settings | |
| Kamal Sharma,A B Chandorkar,Rajiv Kovil,S Venkataraman,KAV Subrahmanyam,Parthasarathi Mandal,Jasjeet Wasir,Mahesh Abhyankar,Ashish Prasad,Prashant S Sarda |
| Cureus.2021;28(3-4)112 |
| [DOI] |
|
| 9 | Evaluation and Characterization of Health Economics and Outcomes Research in SAARC Nations | |
| Manthan Mehta,Rajan Nerurkar |
| Therapeutic Innovation & Regulatory Science.2018;52(3)348 |
| [DOI] |
|
| 10 | Assessment of the quality and trend of reporting of health economic evaluation research in India | |
| Sonali Karekar,Yashashri Shetty |
| Expert Review of Pharmacoeconomics & Outcomes Research.2021;21(4)595 |
| [DOI] |
|
| 11 | A retrospective cross-sectional descriptive study to critically appraise the quality of reporting of health economic evaluations conducted in the Indian setting | |
| SandeepKumar Gupta,RaviKant Tiwari,RajKumar Goel |
| Perspectives in Clinical Research.2022;13(1)25 |
| [DOI] |
|
| 12 | Assessing the Application of Pharmacoeconomic Evaluations in Medicines Management by Hospital Pharmacists in Nigeria: A Cross-Sectional Survey | |
| Theophilus Ehidiamen Oamen,Kanayo Patrick Osemene,Romanus Maduabuchi Ihekoronye |
| Hospital Topics.2021;13(1)1 |
| [DOI] |
|
| 13 | COST ANALYSIS OF DISEASE MODIFYING ANTI RHEUMATIC DRUGS: THE INDIAN SCENARIO | |
| Zarrin Ansari,Sharmada Nerlekar,Sagar Karia,Sudhir Pawar |
| GLOBAL JOURNAL FOR RESEARCH ANALYSIS.2020;13(1)1 |
| [DOI] |
|
| 14 | Knowledge Assessment of E-Bug Assisted Antimicrobial Resistance Education Module in Class VII School Students of South Indian Coastal Town of Manipal | |
| Reona Fernandes,Swathi Naik,Archana-Gururaj Bhat,Rashmi Shetty,Manjunatha-H Hande,Abdul Ghafur,Mahadev Rao,Vijayanarayana Kunhikatta,John-Preshanth-Kumar Pathiraj |
| Journal of Clinical Medicine.2019;8(1)84 |
| [DOI] |
|
